Some HIV-positive Ugandans' not receiving antiretrovirals

Some HIV-positive people in Uganda "cannot be put on the national antiretroviral [ARV] programme because it is already saturated and funds for new patients are not available," the Independent reports. According to the newspaper, roughly 360,000 HIV-positive Ugandans are eligible for antiretroviral treatment because their CD4 counts are below the WHO's threshold of 350; however, about half of them currently do not have access to ARVs.

According to the Independent, Uganda's ARV program "is 95% donor-funded," which includes donations from PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria. Uganda's current allocation for malaria drugs and ARV treatment is $30 million, and the government has budgeted the same amount of money for the 2009/10 fiscal year, according to the publication (Katende, 8/18).

In a recent New Vision opinion piece - John Hoover, the chargé d'affaires of the U.S. Mission in Uganda -addressed the shortage of ARVs in the country. He wrote that Uganda is "losing ground" in its fight against HIV/AIDS. "Even with the unprecedented level of funding provided collectively by the Government, the U.S., and other partners to fight HIV/AIDS, there is now a potentially tragic and growing gap between national needs and the funds available to meet them," Hoover writes. He points out that the Global Fund will "resume funding in Uganda," which will "help address the resource gap." "America's commitment will not waver, despite the budget pressures caused by the economic crisis," he writes, adding, "[b]ut without renewed commitment from the Government and from Ugandans to halt the spread of HIV, no amount of money from the U.S., or other development partners ultimately will prevail" (Hoover, 8/6). 

In other coverage, IRIN examines how food shortages in parts of Uganda are causing HIV-positive people to abandon their ARV regimens "in droves." According to the news service, "leaders fear that unless more food becomes available, they will soon be dealing with drug resistance and death." IRIN writes: "Poor nutrition weakens the body's defences against the virus, hastens progress from HIV to AIDS, and makes it difficult to take [ARVs] ... Sufficient food can help reduce some side-effects of [ARVs] and promote adherence to drug regimens" (8/18).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into the mechanisms of efavirenz-induced neurotoxicity